0001140361-15-045449.txt : 20151223 0001140361-15-045449.hdr.sgml : 20151223 20151223105218 ACCESSION NUMBER: 0001140361-15-045449 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151223 DATE AS OF CHANGE: 20151223 EFFECTIVENESS DATE: 20151223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EFFECTOR THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001577561 IRS NUMBER: 455286092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-253725 FILM NUMBER: 151304593 BUSINESS ADDRESS: STREET 1: 11180 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-442-4861 MAIL ADDRESS: STREET 1: 11180 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0707 D LIVE 0001577561 EFFECTOR THERAPEUTICS, INC. 11180 Roselle Street Suite A SAN DIEGO CA CALIFORNIA 92121 858-442-4861 DELAWARE None None Corporation true 2012 Stephen T. Worland, Ph.D. c/o eFFECTOR Therapeutics, Inc. 11180 Roselle St., Ste. A San Diego CA CALIFORNIA 92121 Executive Officer Director Laurence Lasky c/o eFFECTOR Therapeutics, Inc. 11180 Roselle St., Ste. A San Diego CA CALIFORNIA 92121 Director Simeon George c/o eFFECTOR Therapeutics, Inc 11180 Roselle St., Ste. A San Diego CA CALIFORNIA 92121 Director Ken Haas c/o eFFECTOR Therapeutics, Inc. 11180 Roselle St., Ste. A San Diego CA CALIFORNIA 92121 Director Markus Goebel c/o eFFECTOR Therapeutics, Inc. 11180 Roselle St., Ste. A San Diego CA CALIFORNIA 92121 Director Jonathan Root c/o eFFECTOR Therapeutics, Inc. 11180 Roselle St., Ste. A San Diego CA CALIFORNIA 92121 Director David Maki c/o eFFECTOR Therapeutics, Inc. 11180 Roselle St., Ste. A San Diego CA CALIFORNIA 92121 Director Alana McNulty c/o eFFECTOR Therapeutics, Inc. 11180 Roselle St., Ste. A San Diego CA CALIFORNIA 92121 Executive Officer Biotechnology Decline to Disclose 06b false 2015-12-11 false true false 0 45000005 40000004 5000001 false 17 0 0 0 false EFFECTOR THERAPEUTICS, INC. /s/ Stephen T. Worland, Ph.D. Stephen T. Worland, Ph.D. President and Chief Executive Officer 2015-12-23